Last Updated: August 10, 2026

Litigation Details for Health Grades, Inc. v. MDX Medical, Inc. (D. Colo. 2011)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Health Grades, Inc. v. MDX Medical, Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Health Grades, Inc. v. MDX Medical, Inc. (D. Colo. 2011)

Last updated: July 30, 2026

Litigation summary and analysis for Health Grades, Inc. v. MDX Medical, Inc., 1:11-cv-00520

Executive summary: Health Grades, Inc. sued MDX Medical, Inc. in the U.S. District Court docketed as 1:11-cv-00520. The case centers on claims brought by Health Grades against MDX Medical. The litigation posture and case outcome cannot be stated from the information provided (no court, date, asserted claims, pleadings, filings, or dispositive/judgment dates are included).

What claims were asserted in Health Grades, Inc. v. MDX Medical, Inc., 1:11-cv-00520?

Featured answer: The asserted claims and the legal theories in 1:11-cv-00520 are not specified in the provided input, so a claim-level summary cannot be produced.

Which legal theories were pleaded (copyright, trademark, patent, trade secret, contract, or unfair competition)?

No claim categories, statutes, or complaint allegations are included in the input.

What relief was requested (injunction, damages, attorneys’ fees)?

No relief requests, damage theories, or fee-shifting provisions are provided.

When did Health Grades, Inc. file the complaint and when did MDX Medical respond in 1:11-cv-00520?

Featured answer: Filing dates and response deadlines (answer, motion to dismiss, or other responsive pleadings) are not provided, so timeline reconstruction is not possible.

What key procedural milestones occurred (motion to dismiss, claim construction, discovery orders)?

No milestone dates or docket events are included.

Did the court set any scheduling order, stay, or expedited timetable?

No scheduling or case-management orders are described.

How did the case progress procedurally in 1:11-cv-00520?

Featured answer: Procedural progression (motions, evidentiary hearings, summary judgment, trial, or settlement) is not provided.

Were there dispositive motions (12(b)(6), summary judgment, Daubert)?

No motion titles, grounds, or hearing outcomes are included.

Were any claims dismissed and which parties remained?

No dismissal orders or remaining-claim structure is included.

What is the litigation outcome in Health Grades, Inc. v. MDX Medical, Inc., 1:11-cv-00520?

Featured answer: The case outcome (judgment for plaintiff, defendant, settlement, voluntary dismissal, or other disposition) is not provided.

Did the court issue a final judgment or was the case settled?

No final disposition information is included.

What did the judgment cover (liability, damages, injunctive relief)?

No judgment content is provided.

How do docket events map to litigation risk for MDX Medical and Health Grades?

Featured answer: Without the docket’s motion and disposition history, litigation risk cannot be quantified or mapped to actionable stages.

What were the likely inflection points (early dismissal, claim narrowing, evidentiary rulings)?

No inflection-point rulings are included.

Did any appeals occur?

No appellate history is included.

What settlement terms, consent decrees, or covenants exist for 1:11-cv-00520?

Featured answer: No settlement agreement terms, confidentiality terms, consent injunctions, or covenant-not-to-sue provisions are provided.

Were there non-monetary restrictions (license scope, product redesign, marketing changes)?

No terms are described.

Were there payment obligations and when were they due?

No payment terms or timelines are included.

What commercial exposure does the dispute present?

Featured answer: Commercial exposure depends on the claims, remedies sought, and outcome. None of those are provided.

How might an injunction have affected product sales or branding?

No injunction or outcome is provided.

Could damages be material relative to revenue?

No damages award, settlement amount, or remedy scope is provided.

What is the strength of Health Grades’ asserted positions based on reported filings?

Featured answer: Strength analysis requires the complaint’s theory, supporting allegations, claim elements, defenses, and rulings. None are supplied.

Which arguments drove court decisions (legal standards and factual findings)?

No court reasoning is provided.

What defenses were successful or failed?

No defenses or rulings are provided.

Key Takeaways

  • The input identifies the case as Health Grades, Inc. v. MDX Medical, Inc. | 1:11-cv-00520, but provides no claim details, procedural history, court orders, or outcome.
  • A litigation summary and analysis cannot be completed without docket facts such as the complaint basis, motion practice, dispositive rulings, and final disposition.

FAQs

  1. What claims did Health Grades allege against MDX Medical in 1:11-cv-00520?
  2. What dates define the litigation timeline (complaint filing, answer, dispositive motions, judgment)?
  3. Was any portion of the case dismissed in whole or part under Rule 12 in 1:11-cv-00520?
  4. Did the parties reach a settlement or consent judgment, and what were the terms?
  5. Are there related cases involving the same parties or the same dispute that affect risk assessments?

References

  1. (No sources were provided in the prompt.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.